These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26200947)

  • 1. Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism.
    Mehrotra P; Patel JB; Ivancic CM; Collett JA; Basile DP
    Kidney Int; 2015 Oct; 88(4):776-84. PubMed ID: 26200947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats.
    Mehrotra P; Collett JA; McKinney SD; Stevens J; Ivancic CM; Basile DP
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F385-F397. PubMed ID: 27852609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia.
    Mehrotra P; Collett JA; Gunst SJ; Basile DP
    Am J Physiol Regul Integr Comp Physiol; 2018 Feb; 314(2):R265-R273. PubMed ID: 29118018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel Orai1 promotes lymphocyte IL-17 expression and progressive kidney injury.
    Mehrotra P; Sturek M; Neyra JA; Basile DP
    J Clin Invest; 2019 Nov; 129(11):4951-4961. PubMed ID: 31415242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of Central (Pro)renin Receptor Ameliorates Salt-Induced Renal Injury in Chronic Kidney Disease.
    Li J; Liang M; Zeng T; Qiu M; Zhang M; Jiang S; Tan L; Li A
    Antioxid Redox Signal; 2021 Jul; 35(2):93-112. PubMed ID: 32757619
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
    Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects on long-term function of injured and contralateral kidneys following unilateral renal ischemia-reperfusion.
    Basile DP; Leonard EC; Tonade D; Friedrich JL; Goenka S
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F625-35. PubMed ID: 22114210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Salt-Induced Reno-Cerebral Reflex Activates Renin-Angiotensin Systems and Promotes CKD Progression.
    Cao W; Li A; Wang L; Zhou Z; Su Z; Bin W; Wilcox CS; Hou FF
    J Am Soc Nephrol; 2015 Jul; 26(7):1619-33. PubMed ID: 25635129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
    Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH; Chu TS; Lin SL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
    Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
    Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
    Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Renin-Angiotensin System Inhibitors on Renal Expression of Renalase in Sprague-Dawley Rats Fed With High Salt Diet.
    Wang Y; Xie BQ; Gao WH; Yan DY; Zheng WL; Lv YB; Cao YM; Hu JW; Yuan ZY; Mu JJ
    Kidney Blood Press Res; 2015; 40(6):605-13. PubMed ID: 26619289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.
    Polichnowski AJ; Griffin KA; Licea-Vargas H; Lan R; Picken MM; Long J; Williamson GA; Rosenberger C; Mathia S; Venkatachalam MA; Bidani AK
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1086-F1099. PubMed ID: 32174143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive rats.
    Miloradović Z; Ivanov M; Jovović Đ; Karanović D; Vajić UJ; Marković-Lipkovski J; Mihailović-Stanojević N; Milanović JG
    J Physiol Biochem; 2016 Dec; 72(4):813-820. PubMed ID: 27534651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
    Tsuprykov O; Ando R; Reichetzeder C; von Websky K; Antonenko V; Sharkovska Y; Chaykovska L; Rahnenführer J; Hasan AA; Tammen H; Alter M; Klein T; Ueda S; Yamagishi SI; Okuda S; Hocher B
    Kidney Int; 2016 May; 89(5):1049-1061. PubMed ID: 27083282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.
    Naito T; Ma LJ; Yang H; Zuo Y; Tang Y; Han JY; Kon V; Fogo AB
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F683-91. PubMed ID: 20042458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.